SOX9, a highly sensitive and specific marker to discriminate hepatocellular carcinoma from intrahepatic cholangiocarcinoma

被引：0
|
作者：
Ding, X. [1 ]
Trac, B. [1 ]
Duan, X. [1 ]
机构：
[1] Loyola Univ Med Ctr, Maywood, IL 60153 USA
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-21-004
引用
收藏
页码：S214 / S214
页数：1
相关论文
共 50 条
  • [11] Hepatocyte-derived intrahepatic cholangiocarcinoma requires Yap and Sox9: A clinical and preclinical analysis
    Monga, Satdarshan
    Ko, Sungjin
    Molina, Laura
    Tao, Junyan
    Singhi, Aatur D.
    Bell, Aaron
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [12] Identification of a specific Sertoli cell marker, Sox9, for use in transplantation
    Hemendinger, RA
    Gores, P
    Blacksten, L
    Harley, V
    Halberstadt, C
    CELL TRANSPLANTATION, 2002, 11 (06) : 499 - 505
  • [13] A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma
    Wang, Mengmeng
    Gao, Yuzhen
    Feng, Huijuan
    Warner, Elisa
    An, Mingrui
    Jia, Jian'an
    Chen, Shipeng
    Fang, Meng
    Ji, Jun
    Gu, Xing
    Gao, Chunfang
    CANCER MEDICINE, 2018, 7 (03): : 646 - 654
  • [14] Prognostic and diagnostic value of SOX9 in cirrhotic and noncirrhotic hepatocellular carcinoma
    Xu, Zhong-Ping
    Liu, Yan
    Wu, Zhen-Ru
    Gong, Jian-Ping
    Wang, Yun-Bing
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (06) : 2738 - +
  • [15] Analysis of Sox9 expression in multi-step carcinogenesis and its oncogenic roles in intrahepatic cholangiocarcinoma
    Matsushima, Hajime
    Kuroki, Tamotsu
    Kitasato, Amane
    Adachi, Tomohiko
    Hirabaru, Masataka
    Fujita, Fumihiko
    Kanetaka, Kengo
    Takatsuki, Mitsuhisa
    Kinoshita, Naoe
    Eguchi, Susumu
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E113 - E113
  • [16] Sox9 is highly expressed in nonampullary duodenal adenoma and carcinoma in humans
    Sakamoto, Hirotsugu
    Mutoh, Hiroyuki
    Miura, Yoshimasa
    Yamamoto, Hironori
    Sugano, Kentaro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 388 - 389
  • [17] Therapeutic implication of SOX9 and YAP1 co-repression in advanced intrahepatic cholangiocarcinoma
    Hu, Shikai
    Molina, Laura
    Tao, Junyan
    Liu, Silvia
    Hassan, Mohammed
    Singh, Sucha
    Poddar, Minakshi
    Nejak-Bowen, Kari
    Oertel, Michael
    Raeman, Reben
    Singhi, Aatur
    Bell, Aaron
    Monga, Satdarshan P.
    Ko, Sungjin
    FASEB JOURNAL, 2022, 36
  • [18] Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma
    Guo, Xiaodong
    Xiong, Lu
    Sun, Ting
    Peng, Ruiyun
    Zou, Lin
    Zhu, Haiyan
    Zhang, Jing
    Li, Hanwei
    Zhao, Jingmin
    DIAGNOSTIC PATHOLOGY, 2012, 7
  • [19] Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma
    Xiaodong Guo
    Lu Xiong
    Ting Sun
    Ruiyun Peng
    Lin Zou
    Haiyan Zhu
    Jing Zhang
    Hanwei Li
    Jingmin Zhao
    Diagnostic Pathology, 7
  • [20] Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics
    Liu, Ning
    Wu, Yaokun
    Tao, Yunyun
    Zheng, Jing
    Huang, Xiaohua
    Yang, Lin
    Zhang, Xiaoming
    CANCERS, 2023, 15 (22)
12345